Meloxicam Teva

Meloxicam, the active ingredient in Meloxicam Teva, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain in adults.

GNH USA supplies Meloxicam Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders.

Osteoarthritis: alleviates joint pain and improves function. Rheumatoid arthritis: decreases inflammatory activity and joint swelling. Ankylosing spondylitis: relieves spinal stiffness and pain. Acute pain: provides rapid analgesia for short‑term musculoskeletal discomfort.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort such as dyspepsia or nausea. - Headache or dizziness. - Mild elevation of liver enzymes. - Peripheral edema. - Skin rash or pruritus.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Severe hepatic injury. - Renal impairment or failure. - Cardiovascular events such as myocardial infarction. - Severe hypersensitivity reactions including Stevens‑Johnson syndrome.

Before prescribing, consider patient‑specific risk factors and monitor appropriately.

Renal function: assess baseline creatinine and adjust use in renal impairment. Cardiovascular risk: avoid in patients with recent myocardial infarction or uncontrolled hypertension. Gastro‑intestinal history: use cautiously in those with ulcer disease or bleeding disorders. Pregnancy & lactation: safety not established; weigh benefits against potential risks. Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture and light.

Meloxicam may interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Lithium: elevated serum lithium levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may impair renal clearance of meloxicam. - Methotrexate: potential for increased toxicity.